This content is from: Home

French decision distorts burden of proof for share sale VAT deductibility

The French State Council’s ruling in the Pfizer Holding case has changed the burden of proof for the VAT deductibility of costs related to the sale of shares.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial